mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
NF

Ngl Fine-Chem Limited

NSE:NGLFINEBSE:NGLFINE
HealthcarePharmaceuticals & Biotechnology
₹2,924.0
+0.5%1 Oct close
Mkt cap
₹1,813 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
AnnualQuarterly
ConsolidatedStandalone

Consolidated figures · ₹ crore

₹ CrSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
808810091938995104120128149139
COGS364147474444485257607161
Gross profit444752444946475263687878
303337343840414146465754
141416912561117222123
OPM %17.4%15.8%15.9%10.3%12.4%5.7%6.6%10.5%14.3%17.5%14.4%16.7%
Depreciation333333345555
Interest000001111111
34465-0-162527
Profit before tax1414161213111213211824
Tax34434-0133546
Tax %24.8%30%23.4%21.8%26.4%-0.8%49.1%22%25.8%24.1%24.3%24.8%
10101291011910161318
PAT margin %13.1%11.4%12.4%10.2%10.5%1.4%0.6%8.9%8%12.3%9%13.2%
EPS (₹)1716.22014.915.92.10.91515.625.421.829.8
Results filing———————Results filing for Jun 2025Results filing for Sep 2025Results filing for Dec 2025Results filing for Mar 2026Results filing for Jun 2026

vs same quarter last yearSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue YoY %+18.4%+22.3%+35%+27.7%+16.6%+1.3%-4.8%+14.8%
+28.6%
+43.1%
+57.1%
+33.6%
PAT YoY %+124.4%+54.5%+32.2%+8.3%-6.4%-87.2%-95.6%+0.2%-1.8%+1,125.8%+2,398.1%+99.1%